3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
2
Stomach Neoplasms
1
Primary Breast Cancer
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid
1
Leukemia
1
Gallbladder Neoplasms
1
Esophageal Neoplasms
1
Colonic Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
Oxaliplatin
81
S 1 (combination)
55
Capecitabine
44
apatinib
32
Paclitaxel
32
Docetaxel
32
Irinotecan
27
Fluorouracil
22
Drug Therapy
21
sintilimab
20
Cisplatin
20
Leucovorin
16
Hyperthermic Intraperitoneal Chemotherapy
13
XELOX
12
Surgical Procedures, Operative
12
camrelizumab
10
Trastuzumab
10
titanium silicide
9
Tegafur
9
Nivolumab
9
Neoadjuvant Therapy
9
pembrolizumab
8
Laparoscopy
8
Gastrectomy
8
Folfox protocol
7
Chemotherapy, Adjuvant
7
toripalimab
6
tislelizumab
6
Ramucirumab
6
Gastroscopy
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Stomach Neoplasms
×
Anthracyclines
×
Clear all
NCT03668418
2018-09-12
xenoZ
University of Pisa
Unknown
120 enrolled